(Q41210261)

English

The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Donnelly SM

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Smith EK

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

publication date

1 November 1990

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

487-490

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980065-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980065-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980065-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980065-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980065-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aluminum inhibits erythropoiesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980065-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0272-6386(12)80065-5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41210261&oldid=2094324149"